CSNK2A1/CK II alpha anticorps (pTyr255)

N° du produit ABIN7180665

L’anticorps Lapin Polyclonal anti-CSNK2A1/CK II alpha a été validé pour WB, ELISA et IHC. Il convient pour détecter CSNK2A1/CK II alpha dans des échantillons de Humain.

Aperçu rapide pour CSNK2A1/CK II alpha anticorps (pTyr255) (ABIN7180665)

Antigène: CSNK2A1/CK II alpha (CSNK2A1) (Casein Kinase 2 alpha 1 (CSNK2A1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CSNK2A1/CK II alpha est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Détail du produit anti-CSNK2A1/CK II alpha anticorps

Épitope: pTyr255

Réactivité croisée: Humain, Souris, Rat

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogène: Synthesized peptide derived from Human Casein Kinase IIalpha around the phosphorylation site of Y255.

Isotype: IgG

Information d'application

Indications d'application: WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:10000,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur CSNK2A1/CK II alpha

Antigène: CSNK2A1/CK II alpha (CSNK2A1) (Casein Kinase 2 alpha 1 (CSNK2A1))

Autre désignation: CSNK2A1

Sujet: Casein kinase 2 alpha 1 polypeptide antibody, Casein kinase II alpha 1 antibody, Casein kinase II alpha 1 subunit antibody, Casein kinase II alpha subunit antibody, Casein kinase II subunit alpha antibody, CK II alpha antibody, CK II antibody, CK2 alpha antibody, CK2 catalytic subunit alpha antibody, CK2A1 antibody, CKII antibody, CKIIalpha antibody, CSK21_HUMAN antibody, CSNK2A1 antibody

UniProt: P68400

Pathways: SARS-CoV-2 Protein Interactome